NOVAVAX INC Commitments and Contingencies
NOVAVAX INC (NVAX) had Commitments and Contingencies of $0 as of 2018-09-30, per its 10-Q filed 2018-11-07.
Discontinued › Balance Sheet › Liabilities
us-gaap:CommitmentsAndContingencies · last filed 2018-11-07
- 2018-09-30: Commitments and Contingencies $0.00.
- 2018-06-30: Commitments and Contingencies $0.00.
- 2018-03-31: Commitments and Contingencies $0.00.
- 2017-12-31: Commitments and Contingencies $0.00.
| Period end | Commitments and Contingencies |
|---|---|
| 2018-09-30 | $0.00 10-Q · filed 2018-11-07 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-08 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-09 |
| 2017-12-31 | $0.00 10-Q · filed 2018-11-07 |
| 2015-12-31 | $0.00 10-K · filed 2016-02-29 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-09 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-10 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-07 |
| 2014-12-31 | $0.00 10-K · filed 2016-02-29 |
| 2013-12-31 | $0.00 10-K · filed 2015-02-27 |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-09 |
| 2010-12-31 | $0.00 10-Q · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |